Silva Paul M has filed 5 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 10925 shares of Rapport Therapeutics, Inc. ($RAPP) on June 17, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 17, 2025 | Rapport Therapeutics, Inc. | $RAPP | Silva Paul M | Not found | A | Stock Option (Right to Buy) | 10925 | $0.00 | 10,925.0000 | 36,496,437 | 9999.99% | 0.03% |
| May 19, 2025 | Nurix Therapeutics, Inc. | $NRIX | Silva Paul M | Director | A | Director Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 75,886,817 | 9999.99% | 0.03% |
| Nov. 7, 2024 | Rapport Therapeutics, Inc. | $RAPP | Silva Paul M | Not found | A | Stock Option (Right to Buy) | 29756 | $0.00 | 29,756.0000 | 0 | 9999.99% | 0.00% |
| May 20, 2024 | Nurix Therapeutics, Inc. | $NRIX | Silva Paul M | Director | A | Director Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 54,337,901 | 9999.99% | 0.05% |
| May 4, 2023 | Nurix Therapeutics, Inc. | $NRIX | Silva Paul M | Director | A | Director Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 48,607,990 | 9999.99% | 0.05% |